Dr. Peter Marks, an ex-FDA vaccine official, is warning of a fundamental change at the agency—where vaccine skepticism now ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

A purge of FDA staff spared some people tasked with responding to a judge’s orders to disclose government records on covid vaccines, according to agency employees. The FOIA litigation was brought by ...

The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...

The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...

The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.

FRIDAY, April 4, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has delayed the full approval of Novavax’s COVID-19 vaccine. The decision had been expected by April 1, but the ...

In an emailed statement to The Fly, Novavax (NVAX) said, “As we have previously stated, we believe that our Biologics License Application for ...

A group of Democratic state attorneys general on Thursday sued the Trump administration in an effort to stop it from cutting ...

Novavax started the week hoping the FDA would issue a full approval of its Covid vaccine. But the decision never came.

“We are confident our well-tolerated vaccine represents an important alternative to mRNA Covid-19 vaccines for the US,” Novavax said. The FDA’s press office was put on administrative leave ...